One therapeutic approach to stroke is the transplantation of cells capable of trophic support, reinnervation, and/or regeneration. Previously, we have described the use of novel truncated isoforms of SV40 large T antigen to generate unique cell lines from several primary rodent tissue types. Here we describe the generation of two cell lines, RTC3 and RTC4, derived from primary mesencephalic tissue using a fragment of mutant T antigen, T155c (cDNA) expressed from the RSV promoter. Both lines expressed the glial markers vimentin and S100β, but not the neuronal markers NeuN, MAP2, or β-III-tubulin. A screen for secreted trophic factors revealed substantially elevated levels of platelet-derived growth factor (PDGF) in RTC4, but not RTC3 cells. When transplanted into rat cortex, RTC4 cells survived for at least 22 days and expressed PDGF. Because PDGF has been reported to reduce ischemic injury, we examined the protective functions of RTC4 cells in an animal model of stroke. RTC4 or RTC3 cells, or vehicle, were injected into rat cortex 15-20 min prior to a 60-min middle cerebral artery ligation. Forty-eight hours later, animals were sacrificed and the stroke volume was assessed by triphenyl-tetrazolium chloride (TTC) staining. Compared to vehicle or RTC3 cells, transplanted RTC4 cells significantly reduced stroke volume. Overall, we generated a cell line with glial properties that produces PDGF and reduces ischemic injury in a rat model of stroke.
INTRODUCTION
living but did not significantly improve motor function (12) . In rodents, we have previously demonstrated that transplantation of fetal kidney cells reduces cerebral inThe goal of cellular transplantation for the treatment of neurodegenerative disorders is to deliver cells capable farction after middle cerebral artery occlusion (4). These cells express trophic factors, such as glial-derived neuroof providing trophic factors, preventing further degeneration, promoting neurogenesis and synaptogenesis, or trophic factor (GDNF) or bone morphogenetic proteins (BMPs), after grafting. Similar to GDNF and BMPs, fereestablishing functional neural connections that ultimately correct the neurological deficit. Over the past tal kidney cell transplants reduce ischemic injury through the inhibition of apoptosis. Transplantation-mediated two decades, transplantation of genetically modified cells has been increasingly utilized as a means of a more protection has also been shown using kidney-derived cell lines. For example, grafting kidney cell lines 6509 customized platform of treatment. Ideally, cellular material that undergoes differentiation once transplanted and and 1570 reduces infarct volume and behavioral deficits in stroke rats (9). Because these cell lines contain high continues to exert its desired therapeutic effect can be a powerful therapeutic tool. levels of GDNF and platelet-derived growth factor (PDGF), it is possible that protection is achieved through Cell transplantation has been studied in human clinical trials and animal models of stroke. Phase 2 human the action of these trophic factors produced by the cells. There are several reports indicating that PDGF is trials have demonstrated the safety and feasibility of transplanting neural cells in patients. Cells transplanted neuroprotective against ischemia/hypoxia injury. Hypoxia or ischemia alters the expression of PDGF and its into stroke patients with motor deficits improved daily receptors in the brain (13, 14, 18) . Continuous infusion HBSS, and counted using trypan blue exclusion to assess viability. Viability of both cell lines was >95%. of PDGF-BB increases viable pyramidal neurons while decreasing TUNEL-positive neurons in the hippocampal Cells were resuspended at 1 × 10 4 viable cells/µl in 1× HBSS in the presence of 1 U/ml DNAseI. CA1 region of gerbils after transient common carotid occlusion (8,10). Prolonged infusion of PDGF with imIn Vitro Immunostaining planted osmotic pumps also reduces cerebral infarction induced by focal ischemia in rats (19) . These data sugCells were plated in 24-well dishes at a density of 1 × 10 5 cells per well and allowed to attach overnight. gest that PDGF is effective in neuroprotection during prolonged infusion. It is not known if continuous release Cells were fixed with an ice-cold methanol/acetone (80: 20) solution at room temperature for 10 min. Following of PDGF from immortalized cells lines can also induce similar protection in stroke animals.
three washes with phosphate-buffered saline (PBS), cells were permeabilized with 0.2% Triton X-100 suppleCells, both neurons and glia, of the developing ventral mesencephalon express trophic factors and extracelmented with 0.1% bovine serum albumin (BSA) in PBS for 10 min. The cells were then incubated overnight at lular matrix molecules important for neuronal survival and differentiation. For example, brain-derived neuro-4°C with primary antibody (anti-GFAP, Dako, Carpinteria, CA; mouse anti-β-III-tubulin, Promega, Madison, trophic factor (BDNF), GDNF, neurotrophin-3 (NT-3), and PDGF (22) are expressed by cells of the developing WI; mouse anti-MAP2, BD Biosciences, San Jose, CA; mouse anti-S100β, Alpha Diagnostics, San Antonio, ventral mesencephalon or adult midbrain (16, 20, 22, 23, 32) . Each of these molecules has been shown to be bene-TX; mouse anti-NeuN, Chemicon, Temecula, CA; and mouse anti-vimentin, Sigma-Aldrich, St. Louis, MO) dificial in models of stroke when applied exogenously (7, 10, 11, 13, 19, 21, 27, 30, 31) . Based on the production of luted 1:500 in a blocking buffer of PBS supplemented with 0.1% BSA. Cells were rinsed three times for 2 min trophic factors in the developing VM, we used the truncated T antigen molecule, T155c, to generate an immoreach with 0.05% Tween-20 in PBS. Cells were then incubated for 1 h with secondary antibodies (anti-rabbit or talized rat cell line from VM capable of trophic factor production. We found that the resulting cell line, RTC4, anti-mouse Alexa Fluor, Invitrogen) diluted in blocking buffer. Nuclei were stained with DAPI (Sigma). Cells secreted high levels of PDGF in vitro and reduced infarction volume when transplanted in a rat model of were viewed using a Zeiss Axiovert inverted microscope with appropriate filters. Images were captured with a stroke.
Photometrics Cool Snap digital camera and IPLab soft-
MATERIALS AND METHODS
ware. Constructs ELISA The RSVT155c plasmid was constructed as pre-RTC3 or RTC4 cells were seeded at 1 × 10 6 cells per viously described (6,24). Briefly, a gene fragment codwell in a six-well plate and allowed to attach overnight. ing for the first 155 amino acids of the SV40 large T Medium was changed the next day for zero time point antigen was generated by the polymerase chain reaction and then collected 48 h later for analysis of PDGF (PCR) and subcloned into the pRc-RSV vector back-(R&D Systems, Minneapolis, MN), BDNF, GDNF, NTbone.
3, and NGF (Promega, Madison, WI) according to the Cell Culture manufacturer's recommendations. PDGF was also assayed at 4 and 6 days postplating. Cells were fixed with Mesencephalic tissue from E14 Sprague-Dawley rat pups was manually dissected, dissociated, and cultured 4% paraformaldehyde and stained with DAPI to identify cell nuclei. Nuclei were counted in a subset of fields and as previously described (24) . Primary cells were transfected on 2 consecutive days with RSVT155c using the the total number of DAPI cells was extrapolated and used to normalize ELISA data. FuGENE transfection reagent (Roche Applied Science, Indianapolis, IN). Transfected cultures were selected usLabeling Cells With AAVGFP ing 500 µM G418 for 2 weeks. Surviving cells were cloned and expanded. Cell lines were maintained in a
The construction of the self-complementing AAV vector expressing eGFP, dsAAVGFP, has been de-5% CO 2 incubator in Dulbecco's modified Eagle's medium/Ham's F12 (DMEM/F12, 1:1, Gibco Life Techscribed previously (28) . Viral stocks were prepared using the triple-transfection method (29) . Briefly, 15-cm nologies, Gaithersburg, MD) containing 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml penicillin G, and dishes containing HEK293 cells at 85-95% confluent were transfected by the CaCl 2 method with pHelper 100 µg/ml streptomycin.
For transplantation, cells were grown for 5 days after (Stratagene, Cedar Creek, TX), pdsAAVGFP, and a plasmid containing capsid protein pXX2 (pdsAAVGFP plating, collected by trypsinization, washed with 1× and pXX2 plasmids were generously provided by Dr. tion was measured by blinded investigators using ImageTool v3.0 (UTHSCSA). Volume of infarction was Xiao Xiao, University of Pittsburgh). Approximately 48 h posttransfection, cells were harvested, lysed by freeze/ calculated by multiplying the area of infarction per slice by the thickness of the slice (2 mm) and then summing thaw, and purified by centrifugation on CsCl gradient. Final samples were dialyzed in PBS containing 0.5 mM the volumes over the slices. MgCl 2 , aliquoted, and stored at −80°C until use. All vec-
In Vivo Immunostaining tors were titered by quantitative PCR using GFP as the Rats were anesthetized with chloral hydrate (0.4 g/kg, target sequence. Infection of RTC3 and RTC4 cells prior IP) and perfused transcardially with saline followed by to transplantation took place over 4 consecutive days 4% paraformaldehyde (PFA) in phosphate buffer (PB; using an MOI of 10,000.
0.1 M; pH 7.2). The brains were removed, postfixed in Animals and Surgery PFA for 48-72 h, and transferred to 18% sucrose in 0.1 M PB for at least 16 h. Serial sections of the entire brain Adult male Sprague-Dawley rats weighing 250-300
were cut at 25 µm with a cryostat. Free-floating sections g were used. Animals were anesthetized with chloral hywere permeabilized/blocked in PB containing 0.3% Tridrate (0.4 g/kg, IP). Three burr holes were drilled (1.25-ton X-100 and 4% BSA for 1 h. Sections were washed mm diameter bit) in the right frontal and parietal plates.
and incubated overnight at 4°C in mouse anti-PDGF (1: Cells were injected at the following stereotaxic coordi-250; Santa Cruz Biotechnologies). Primary antibody was nates relative to bregma: 1.0-2.0 mm anterior-posterior detected using goat anti-mouse Alexa 568 (1:500; Nitro-(AP), 3.5-4.0 mm right medial-lateral (ML), 2-4 mm gen, Carlsbad, CA). Sections were mounted on slides ventral to the dura; −0.5 to −1.5 AP, 4.0-4.5 right ML, using antifade solution (Nitrogen) and viewed using a 2-3 mm ventral to the dura; and −4.0 to −4.5 AP, 5.5-Nikon 80i upright microscope with appropriate filters. 6.0 right ML, 2-3 mm ventral to the dura. Cells were Images were captured with a Retiga Exi digital camera prepared immediately prior to transplantation as deand Q-Capture Pro software. scribed above and then loaded into a 25-µl Hamilton syringe equipped with a glass tip. Five microliters of Statistics RTC3 or RTC4 cells (5 × 10 4 viable cells/µl) or vehicle Student's t-test and one-way ANOVA plus post hoc was injected at 1 µl/min into each site using an Ultra Newman-Keuls analysis were used for statistical comMicroPumpII (World Precision Instruments, Sarasota, parison. Data are presented as means ± SEM. FL). Burr holes were sealed with bone wax after each injection.
RESULTS

Approximately 15-20 min after the last injection of
Cell Line Derivation and Phenotypic Analysis cells, animals were subjected to cerebral ischemia. A subset of animals did not receive middle cerebral artery Transfection of primary rat mesencephalic tissue (MCA) ligation (MCAL) and were allowed to survive with pRSV-T155c and G418 selection yielded multiple 21 days to evaluate the survival of transplanted cells. cell lines. Two clonal lines, RTC3 and RTC4, were caThe temporary ligation of the right MCA and bilateral pable of indefinite propagation in nonspecialized mecommon carotids was performed using methods predium. Morphologically, they appeared fibroblastic and viously described (26) . First a craniotomy was perof similar size (Fig. 1A) . Both RTC3 and RTC4 were formed to expose the right MCA, which was ligated immunoreactive for S100β (Fig. 1B) and vimentin, an with 10-0 suture for 60 min. Core body temperature was intermediate filament protein (Fig. 1C) . Both cell lines monitored with a thermistor probe and maintained at were negative for neuronal markers NeuN, Map2, and 37°C with a heating pad during surgery. After surgery, β-III-tubulin (data not shown). Collectively, these data the animals were kept in a temperature-controlled incusuggest a glial phenotype for RTC3 and RTC4 cell bator to maintained body temperature at 37°C. After relines. covery from the anesthesia, the animals were returned Screening of Secreted Trophic Factors to their home cages.
To further characterize the RTC3 and RTC4 phenoTriphenyltetrazolium Chloride Staining type, medium conditioned for 48 h by either cell line was collected and screened for secreted trophic factors Animals were sacrificed 2 days after MCAL. The brains were removed and sliced into 2.0-mm-thick secby ELISA. BDNF, GDNF, and NGF were not detected above background levels for both cell lines. However, tions. The brain slices were incubated in 2% TTC in saline, and then transferred into a 4% PFA solution in PDGF was found to be produced in high concentrations by RTC4, but not RTC3, medium on DIV2 (p = 0.016, PBS for fixation. The sections were scanned using ScanJet 4c scanner (Hewlett-Packard) and the area of infarct-test) (Fig. 2) . (Fig. 4C, D) . Interestingly, animals pretreated with RTC3 cells did not show significant changes in the inTo identify the transplanted cells, RTC4 cells were transfarction compared to the vehicle control. duced using AAVGFP serotype 2 (Fig. 3A) . AAVGFPlabeled cells were harvested on DIV5 and transplanted DISCUSSION at three sites in the right tempoparietal cortex of adult rats. In all three animals examined, PDGF immunoreacIn this report we generated two cell lines, RTC3 and RTC4, from rat embryonic ventral mesencephalic (VM) tivity was detected at the transplant site, where GFPpositive cells were also present at 22 days posttransplantissue. RTC4, but not RTC3 cells, secreted PDGF in vitro and in vivo. Transplantation of RTC4, but not tation. Diffuse PDGF immunoreactivity also extended beyond the transplantation site identified by GFP-posi-RTC3 cells, reduced infarction volume in a rodent model of stroke, suggesting RTC4 cells may have therative cells (Fig. 3B, C) . peutic value in treating ischemic brain injury.
Survival and PDGF Expression of RTC4 Cells In Vivo
PDGF-Secreting RTC4 Cells Reduce Volume
One concern with transplantation of immortalized of Infarction in Stroke Rats cells is the formation of tumors. For example, the cortical transplantation of a glioblastoma cell line generated A total of 24 rats were used to examine the protective effect of RTC4 and RTC3 after transient middle cerebral using a Rous sarcoma virus results in tumor formation and ultimately death of the animals by 2 weeks postartery occlusion. RTC3, RTC4, or vehicle (n = 8 per group) was injected into the cortex at three sites in the transplantation (15) . Previously, we have described the use of a truncated isoform of the large T antigen moleterritory of the right MCA approximately 15 min prior to a 60-min MCAL. Typical infarctions from animals cule for immortalizing primary tissue (25). This molecule encodes the first 155 amino acids of large T antigen treated with RTC4 and RTC3 cells are shown in Figure  4A . The volume of infarction (thickness of the slice × and is amplified in two forms, T155g (genomic) and T155c (cDNA), named for their PCR template source. sum of the infarction area in all brain slices) was significantly reduced in the animals pretreated with RTC4 cells
The "g" isoform includes the coding sequence for small T antigen, whereas the "c" isoform does not. Small T [F(2, 18) = 13.069, p < 0.001, one-way ANOVA; p < 0.05, post hoc Newman-Keuls test]. The area of the antigen is thought to be critical for cellular transformation and tumorogenicity (1-3,5). In previous studies, largest infarction in a slice was also significantly reduced by RTC4 cells [F(2, 18) = 10.283, p < 0.001, onecell lines created using the small T antigen encoding "g" isoform have failed to generate tumors in vivo (17); way ANOVA; p < 0.05, post hoc Newman-Keuls test] however, the use of the small T negative "c" isoform ing development, and the rationale for using VM as the source tissue for immortalization stems from our experimay add a level of safety for use in long-term transplantation studies. In the present study, we used the trunence in generating therapeutically relevant cell lines from this area. In vivo, the VM develops to contain precated T antigen molecule, T155c, to generate an immortalized rat cell line capable of trophic factor production.
dominantly neurons of a dopaminergic phenotype. However, both RTC3 and RTC4 cells have characteristics of AAVGFP-labeled RTC4 cells were detected at the graft site up to 3 weeks posttransplantation. There were no an astroglial phenotype based on expression of vimentin, S100β, and general morphology in vitro. Both lines exobvious signs of tumor formation or cell growth distal to the injection site within the brain, which may be atpressed low levels of glial fibrillary acidic protein (GFAP) when examined within the first few weeks posttributed to the lack of tumorogenicity by T155c immortalization.
immortalization with T155c antigen; however, GFAP expression diminished over continued passaging (data The VM produces many different trophic factors dur- 
not shown). GFAP is used to identify mature astrocytes
The primary difference observed in our characterization of RTC3 and RTC4 cell lines was the secretion of whereas immature astrocytes express vimentin. These cells were also negative for the neuronal markers NeuN, PDGF, suggesting this property is important for the protective effects seen here; however, it is possible that Map2, and β-III-tubulin. Based on expression of these three glial proteins and the lack of expression of neuother properties of RTC4 cells contributed to their protective effects. Although PDGF may contribute to the ronal proteins it is likely that the RTC3 and RTC4 cells are of astrocytic derivation, immortalized in an immareduced infarction volume, it remains to be determined whether it is the primary source of protection. Further ture state. Of the trophic factors screened, PDGF was detected in medium from RTC4 cells but not RTC3 studies examining the gene expression profile of these two cell lines may aid in identifying the key mediators cells. Previous studies have found that hypoxia/ischemia alters expression of PDGF and its receptors in the brain of protection and potentially identify therapeutic targets for acutely treating stroke. (13,14,18) . Other work has shown that exogenously applied PDGF reduces injury in a rodent model of stroke with PDGF to confer protection at the ischemic area.
